Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer

被引:28
作者
Chirmule, N
Moscioni, AD
Qian, YK
Qian, RZ
Chen, YH
Wilson, JM
机构
[1] Univ Penn, Inst Human Gene Therapy, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA
[2] Univ Penn, Inst Human Gene Therapy, Dept Med, Philadelphia, PA 19104 USA
[3] Wistar Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1089/10430349950019048
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Adenovirus vectors transduce liver hepatocytes with extreme efficiency; however, transgene expression is eliminated within 2 weeks. Extinction of transgene expression has been attributed to infiltrating cytotoxic T lymphocytes (CTLs) in the liver in a process that resembles a number of human diseases, including viral and autoimmune hepatitis. In this study we investigated the role of Fas-Fas ligand interactions in killing of vector-transduced hepatocytes in vitro and irt vivo. Intrahepatic lymphocytes (IHLs) isolated from livers of mice administered adenovirus vector demonstrated cytolytic activity against vector-infected primary hepatocytes, The irt vitro CTL activity of the IHLs involving both CD4(+) and CD8(+) T cells was MHC class I restricted and could be blocked by soluble Fas-IgG, Adoptive transfer of IHLs from immune-competent mice immunized with Ad-lacZ into Rag1-deficient mice previously infused with Ad-lacZ resulted in rapid elimination of beta-galactosidase-transduced hepatocytes. Transfer of these cells into Fas-deficient mice (B6-lpr) failed to eliminate lacZ expression; likewise IHLs from immunized FasL-deficient mice (B6-gld) failed to eliminate lacZ expression in Rag1-deficient mice. Finally, in vivo administration of soluble Fas-IgG abrogated the ability of Ad-lacZ-primed IHLs to eliminate transgene expression. These studies establish an essential role for Fas-Fas ligand interactions in the mechanism of elimination of adenoviral vector-mediated transgene expression in the liver.
引用
收藏
页码:259 / 269
页数:11
相关论文
共 26 条
[1]   Strange brew: T cells in the liver [J].
Crispe, IN ;
Mehal, WZ .
IMMUNOLOGY TODAY, 1996, 17 (11) :522-525
[2]   TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J].
CRYSTAL, RG .
SCIENCE, 1995, 270 (5235) :404-410
[3]   Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors [J].
Elkon, KB ;
Liu, CC ;
Gall, JG ;
Trevejo, J ;
Marino, MW ;
Abrahamsen, KA ;
Song, X ;
Zhou, JL ;
Crystal, RG ;
FalckPedersen, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9814-9819
[4]   TCR-mediated target cell lysis by CD4(+)NK1(+) liver T lymphocytes [J].
Emoto, M ;
Emoto, Y ;
Kaufmann, SHE .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (04) :563-571
[5]   An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow [J].
George, JF ;
Sweeney, SD ;
Kirklin, JK ;
Simpson, EM ;
Goldstein, DR ;
Thomas, JM .
NATURE MEDICINE, 1998, 4 (03) :333-335
[6]   Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis [J].
Giordano, C ;
Stassi, G ;
DeMaria, R ;
Todaro, M ;
Richiusa, P ;
Papoff, G ;
Ruberti, G ;
Bagnasco, M ;
Testi, R ;
Galluzzo, A .
SCIENCE, 1997, 275 (5302) :960-963
[7]   Fas-ligand: Privilege and peril [J].
Green, DR ;
Ware, CF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :5986-5990
[8]   The role of FasL-induced apoptosis in immune privilege [J].
Griffith, TS ;
Ferguson, TA .
IMMUNOLOGY TODAY, 1997, 18 (05) :240-244
[9]   Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis [J].
Hirata, H ;
Takahashi, A ;
Kobayashi, S ;
Yonehara, S ;
Sawai, H ;
Okazaki, T ;
Yamamoto, K ;
Sasada, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) :587-600
[10]   THE LIVER ELIMINATES T-CELLS UNDERGOING ANTIGEN-TRIGGERED APOPTOSIS IN-VIVO [J].
HUANG, L ;
SOLDEVILA, G ;
LEEKER, M ;
FLAVELL, R ;
CRISPE, IN .
IMMUNITY, 1994, 1 (09) :741-749